ANTHONY DEWAR: Open Payments
NPI 1619329166 · CORAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,624 in 41 payments from 6 companies in 2025. Trend: 2023 $569 · 2024 $883 · 2025 $1,624
Food & beverage: $1,553Education: $71
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $543 |
| Teva Pharmaceuticals USA, Inc. | 8 | $346 |
| ABBVIE INC. | 8 | $314 |
| Otsuka America Pharmaceutical, Inc. | 7 | $223 |
| Lundbeck LLC | 4 | $100 |
| E.R. Squibb & Sons, L.L.C. | 3 | $99 |
Products named: VRAYLAR, ARISTADA, UZEDY, LYBALVI, ABILIFY MAINTENA, ABILIFY ASIMTUFII, COBENFY, REXULTI.
Industry payments across NY — which companies pay providers there.
